Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
Alexandrov
Andrei V
AV
The Cerebrovascular Ultrasound Stroke Treatment Team, University of Texas-Houston Medical School, TX 77030, USA. avalexandrov@att.net
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D011446:Prospective Studies; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator